Table 1 Clinical characteristics.
ACS (n = 64) | ACS + T2DM (n = 41) | p-value | |
|---|---|---|---|
Age (years) | 62.09 ± 8.97 | 61.8 ± 9.12 | 0.873† |
Gender (male) | 40 (62.50) | 25 (60.90) | 0.875§ |
BMI (kg/m2) | 24.96 ± 2.53 | 25.29 ± 2.91 | 0.355† |
SBP (mmHg) | 126.33 ± 14.46 | 134.94 ± 15.47 | 0.076† |
DBP (mmHg) | 78.79 ± 8.19 | 77.53 ± 12.57 | 0.699† |
History | |||
Smoking | 27 (42.20) | 17 (41.50) | 0.942§ |
Hypertension | 30 (45.80) | 29 (70.60) | 0.116§ |
Stroke | 5 (7.80) | 3 (7.30) | 0.926§ |
PCI | 13 (20.30) | 7 (17.10) | 0.680§ |
Medication | |||
Aspirin | 57 (89.10) | 37 (90.2) | 0.847§ |
Clopidogrel | 24 (37.50) | 12 (29.30) | 0.386§ |
Ticagrelor | 34 (53.1) | 24 (58.5) | 0.586§ |
Statins | 58 (90.60) | 37 (90.20) | 0.948§ |
Beta-blockers | 32 (50.00) | 28 (66.6) | 0.346§ |
ACEI | 12 (18.80) | 4 (9.80) | 0.211§ |
ARB | 12 (18.8) | 12 (29.30) | 0.210§ |
Laboratory measurement | |||
UA (μmol/l) | 312.83 ± 78.449 | 303.88 ± 83.90 | 0.614† |
CREA (μmol/l) | 65.64 ± 18.12 | 63.51 ± 12.63 | 0.624† |
BUN (mmol/l) | 4.82 (4.23–5.88) | 5.28 (4.27–6.75) | 0.051* |
WBC (*109/l) | 7.70 (5.96–10.02) | 8.38 (6.99–10.20) | 0.328* |
NEUT (%) | 68.75 (54.82–76.93) | 64.40 (57.4–75.85) | 0.768* |
HDL-C (mmol/l) | 0.92 (0.79–1.09) | 0.87 (0.75–0.99) | 0.590* |
LDL-C (mmol/l) | 2.20 (1.66–2.66) | 2.31 (1.58–2.78) | 0.234* |
AST (u/l) | 36.10 (24.65–63.37) | 32.20 (21.6–59.2) | 0.157* |
ALT (u/l) | 31.75 (26.2–45.68) | 31.50 (23.10–46.0) | 0.261* |
TG (mmol/l) | 1.45 (1.03–1.97) | 1.51 (1.19–2.34) | 0.052* |
TC (mmol/l) | 3.74 (3.13–4.33) | 3.72 (3.19–4.29) | 0.634* |
EF (%) | 56.02 (48.86–66.64) | 56.98 (47.55–66.65) | 0.924* |
BNP (pg/ml) | 295.9 (114.99–1258.25) | 513.1 (130.06–1650.80) | 0.182* |
HbA1c (%) | 5.50 (5.40–5.80) | 7.50 (6.65–8.35) | < 0.001* |
FBG (mmol/l) | 5.39 (5.00–5.98) | 8.23 (6.84–10.99) | < 0.001* |
Syntax score I | 18.72 ± 7.90 | 27.84 ± 8.97 | < 0.001† |
MACE | 4 (6.30) | 10 (24.40) | 0.016δ |